Suppr超能文献

基于导管的冠状动脉疾病治疗:过去、现在和未来。

Catheter-based treatment of coronary artery disease: past, present, and future.

机构信息

Mayo Clinic, Rochester, MN 55901, USA.

出版信息

Circ Cardiovasc Interv. 2008 Aug;1(1):60-73. doi: 10.1161/CIRCINTERVENTIONS.108.783134.

Abstract

September 2007 marked the 30-year anniversary of the first human percutaneous coronary intervention, an index event that changed the course of modern-day cardiovascular care. Before that first procedure, adult invasive cardiology focused on diagnostic angiography as well as hemodynamic assessment of structural heart disease. Since that initial procedure, percutaneous coronary intervention has become the most frequently performed coronary revascularization procedure worldwide. Several factors have been responsible for this dramatic paradigm shift, the most prominent being identification of opportunities for technical improvement and the application of innovation and investigation in concert with colleagues, professional societies, and industry. These approaches will continue to be of paramount importance as new technologies are brought to bear on an increasingly broader group of patients with cardiovascular disease.

摘要

2007 年 9 月标志着首例人类经皮冠状动脉介入治疗的 30 周年,这一里程碑事件改变了现代心血管护理的进程。在此之前,成人介入心脏病学主要专注于诊断性血管造影以及结构性心脏病的血流动力学评估。自首例手术以来,经皮冠状动脉介入治疗已成为全球最常施行的冠状动脉血运重建术。有几个因素促成了这一戏剧性的范式转变,其中最突出的是确定了技术改进的机会,并与同事、专业协会和行业一起应用创新和研究。随着新技术应用于越来越广泛的心血管疾病患者群体,这些方法仍将至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验